ITTO20110638A1 - PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES - Google Patents

PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES

Info

Publication number
ITTO20110638A1
ITTO20110638A1 IT000638A ITTO20110638A ITTO20110638A1 IT TO20110638 A1 ITTO20110638 A1 IT TO20110638A1 IT 000638 A IT000638 A IT 000638A IT TO20110638 A ITTO20110638 A IT TO20110638A IT TO20110638 A1 ITTO20110638 A1 IT TO20110638A1
Authority
IT
Italy
Prior art keywords
pathologies
pathological states
methods
combination
pharmaceutical composition
Prior art date
Application number
IT000638A
Other languages
Italian (it)
Inventor
Oleg Iliich Epshtein
Original Assignee
Oleg Iliich Epshtein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO20110638(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130352/15A external-priority patent/RU2528093C2/en
Priority claimed from RU2011125992/15A external-priority patent/RU2529783C2/en
Application filed by Oleg Iliich Epshtein filed Critical Oleg Iliich Epshtein
Publication of ITTO20110638A1 publication Critical patent/ITTO20110638A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT000638A 2010-07-21 2011-07-15 PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES ITTO20110638A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2010130352/15A RU2528093C2 (en) 2010-07-21 2010-07-21 Pharmaceutical composition and method of treating acute and chronic respiratory diseases and cough syndrome
RU2011125992/15A RU2529783C2 (en) 2011-06-24 2011-06-24 Medication for treating pathological syndrome and method of treating acute and chronic respiratory system diseases and cough synrdome

Publications (1)

Publication Number Publication Date
ITTO20110638A1 true ITTO20110638A1 (en) 2012-01-22

Family

ID=44899162

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000638A ITTO20110638A1 (en) 2010-07-21 2011-07-15 PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES

Country Status (22)

Country Link
US (2) US8795657B2 (en)
EP (1) EP2595655A2 (en)
JP (2) JP2013533269A (en)
CN (1) CN103200964A (en)
AR (1) AR082313A1 (en)
AU (1) AU2011281247B2 (en)
BR (1) BR112013001297A2 (en)
CA (1) CA2805978C (en)
CL (1) CL2013000202A1 (en)
DE (1) DE112011102412T5 (en)
EA (1) EA029228B1 (en)
ES (1) ES2425315R1 (en)
FR (1) FR2962909A1 (en)
GB (1) GB2496800B (en)
IT (1) ITTO20110638A1 (en)
MX (1) MX356678B (en)
MY (1) MY158522A (en)
NZ (1) NZ606977A (en)
PE (1) PE20130387A1 (en)
PH (1) PH12013500142A1 (en)
SG (1) SG187579A1 (en)
WO (1) WO2012010973A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
RU2309732C1 (en) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Pressed solid oral formulation of medicinal preparation and method for preparing solid oral formulation of medicinal preparation
FR2962652A1 (en) 2010-07-15 2012-01-20 Oleg Iliich Epshtein PHARMACEUTICAL ASSOCIATION COMPOSITION AND ITS USE IN METHODS FOR TREATING DISEASES OR DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
SG187038A1 (en) 2010-07-15 2013-02-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
EA029199B1 (en) 2010-07-21 2018-02-28 Олег Ильич Эпштейн Combination pharmaceutical composition for treating attention deficit hyperactivity disorder and methods of treating attention deficit hyperactivity disorder
GB2496342B (en) * 2010-07-21 2017-12-06 Iliich Epshtein Oleg Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
KR20180127515A (en) * 2010-07-21 2018-11-28 올레그 일리치 엡쉬테인 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
AU2011281247B2 (en) * 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
NZ606993A (en) * 2010-08-06 2015-11-27 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
RU2013111962A (en) 2013-03-18 2014-09-27 Олег Ильич Эпштейн METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER
RU2013111961A (en) 2013-03-18 2014-09-27 Олег Ильич Эпштейн METHOD FOR DETERMINING THE EXPRESSION OF MODIFICATION ACTIVITY ASSOCIATED WITH A CARRIER
DE102020007979A1 (en) 2020-12-29 2022-06-30 Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie Composition for treating coronavirus infections

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
DE69312077T2 (en) 1992-10-08 1997-10-30 Kennedy Inst Of Rheumatology TREATMENT OF AUTOIMMUNE AND INFLAMMATION DISEASES
IT1261849B (en) 1993-09-02 1996-06-03 Avantgarde Spa MEDICAL DEVICE FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS OR VERY LOW DOSAGE DRUGS, IN PARTICULAR HOMEOPATHIC DRUGS.
US5629286A (en) 1994-03-31 1997-05-13 Brewitt; Barbara Homeopathic dilutions of growth factors
IL110035A0 (en) 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations
US8178498B1 (en) 1996-02-12 2012-05-15 Oleg Iliich Ephstein Medicament and method of treating an organism with medicaments
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2114646C1 (en) 1996-09-30 1998-07-10 Олег Ильич Эпштейн Method of enhancement of organism protective property at effect of external physical factors
RU2103999C1 (en) 1997-01-31 1998-02-10 Олег Ильич Эпштейн Method of alcoholism treatment
RU2181297C2 (en) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
RU2199244C2 (en) * 2000-10-05 2003-02-27 Самофалова Лариса Александровна Method of producing food flour from oil-bearing seeds
RU2191602C1 (en) 2001-06-01 2002-10-27 Эпштейн Олег Ильич Medicinal agent and method of treatment of allergic and pseudoallergic responses
RU2197266C1 (en) * 2001-06-01 2003-01-27 Эпштейн Олег Ильич Medicinal agent and method of treatment of erosive and inflammatory diseases of gastroenteric tract
RU2206338C1 (en) 2001-12-07 2003-06-20 Эпштейн Олег Ильич Method of cough syndrome treatment
RU2199344C1 (en) * 2001-12-07 2003-02-27 Эпштейн Олег Ильич Medicinal agent and method of treatment of cough syndrome
RU2201255C1 (en) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Medicinal agent and method of regulation of vascular tonus
RU2209083C1 (en) 2001-12-26 2003-07-27 Эпштейн Олег Ильич Medicament and method for treating cough
RU2199345C1 (en) 2001-12-26 2003-02-27 Эпштейн Олег Ильич Medicinal agent and method of regulation of carbohydrate and lipid metabolism
UA76639C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medication and method for treating erectile dysfunctions
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76641C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medicinal agent and method for curing diseases of prostate
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
RU2253478C1 (en) 2003-10-01 2005-06-10 Эпштейн Олег Ильич Agent for potentiation therapeutical effects: enhancing effect of drug
MX2008015621A (en) * 2006-06-06 2009-03-06 Oleg Iliich Epshtein Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance.
EA201001592A1 (en) * 2008-04-29 2011-08-30 Гунвант Девичанд Освал HOMEOPATHIC MEDICINE
CN103096927A (en) 2010-07-15 2013-05-08 奥列格·伊里奇·爱泼斯坦 Compound pharmaceutical composition and method for treating gastrointestinal functional diseases or disorders
JP2013535436A (en) * 2010-07-15 2013-09-12 イリイチ・エプシテイン オレグ Pharmaceutical composition and method of treatment
FR2962652A1 (en) * 2010-07-15 2012-01-20 Oleg Iliich Epshtein PHARMACEUTICAL ASSOCIATION COMPOSITION AND ITS USE IN METHODS FOR TREATING DISEASES OR DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
MX354187B (en) 2010-07-15 2018-02-16 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating genitourinary system disorders.
GB2496342B (en) * 2010-07-21 2017-12-06 Iliich Epshtein Oleg Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
AU2011281247B2 (en) * 2010-07-21 2015-07-30 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
KR20180127515A (en) 2010-07-21 2018-11-28 올레그 일리치 엡쉬테인 A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
NZ606993A (en) 2010-08-06 2015-11-27 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating and preventing the infectious diseases

Also Published As

Publication number Publication date
CA2805978C (en) 2016-06-28
US20150023985A1 (en) 2015-01-22
DE112011102412T5 (en) 2013-07-04
CA2805978A1 (en) 2012-01-26
AU2011281247B2 (en) 2015-07-30
SG187579A1 (en) 2013-03-28
WO2012010973A3 (en) 2012-04-26
AR082313A1 (en) 2012-11-28
JP2016216479A (en) 2016-12-22
GB201302926D0 (en) 2013-04-03
GB2496800B (en) 2018-05-23
MX2013000806A (en) 2013-10-28
ES2425315R1 (en) 2014-09-08
FR2962909A1 (en) 2012-01-27
MY158522A (en) 2016-10-14
WO2012010973A2 (en) 2012-01-26
AU2011281247A1 (en) 2013-03-14
PH12013500142A1 (en) 2013-03-11
NZ606977A (en) 2015-08-28
ES2425315A2 (en) 2013-10-14
PE20130387A1 (en) 2013-03-30
EA029228B1 (en) 2018-02-28
GB2496800A (en) 2013-05-22
CN103200964A (en) 2013-07-10
MX356678B (en) 2018-06-08
US8795657B2 (en) 2014-08-05
EP2595655A2 (en) 2013-05-29
JP2013533269A (en) 2013-08-22
CL2013000202A1 (en) 2015-01-16
BR112013001297A2 (en) 2017-11-21
US20120225074A1 (en) 2012-09-06
EA201300131A1 (en) 2013-11-29

Similar Documents

Publication Publication Date Title
ITTO20110638A1 (en) PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING PATHOLOGIES OR PATHOLOGICAL STATES ASSOCIATED WITH PATHOLOGIES OR RESPIRATORY PATHOLOGICAL STATES
HRP20170991T1 (en) MOVEMENT SCREENS AND RELATED PROCEDURES
HUE036439T2 (en) Antimicrobials and methods of their application
HUE049880T2 (en) Materials and methods for treating or preventing Her-3-related diseases
BR112013009069A2 (en) patient-attached instrumentation and methods
EP2413825A4 (en) DORNFORTSATZIMPLANTATE AND RELATED PROCEDURES
HUE040445T2 (en) Antisense molecules and methods for treating diseases
BR112013023776A2 (en) composition and seal-sealed opening
DK2544719T3 (en) CD37-BINDING MOLECULES AND IMMUNCONJUGATES THEREOF
BR112012000568A2 (en) multiple sclerosis treatment with laquinimod
EP2498853A4 (en) PATIENT INTERFACE AND ASPECTS OF IT
EP2658805A4 (en) METHOD AND LIFT ARRANGEMENT
HRP20160579T1 (en) INDOLA COMPOUND AND ITS PHARMACEUTICAL USE
BRPI0912123A2 (en) Salt compositions and production methods thereof
RS56242B1 (en) WNT ANTAGONISTS AND TREATMENT METHODS
ITTO20110628A1 (en) PHARMACEUTICAL COMPOSITION OF COMBINATION AND METHODS FOR TREATING FUNCTIONAL DISORDERS OR PATHOLOGICAL STATES OF THE GASTROINTESTINAL TRACT
EP2646361A4 (en) ELEVATOR ARRANGEMENT AND ASSOCIATED METHOD
PT2582683T (en) TREATMENT OF DROP AND HYPERURICEMIA
PT2683372T (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA
HUE064745T2 (en) Methods and compositions for the diagnosis and treatment of cancer
IL223286A0 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
EP2465593A4 (en) WATER PROCESSING AND WATER PROCESSING AND FLAKING AGENTS
EP2841010A4 (en) MODIFIED TISSUE SCAFFOLDS AND RELATED MEDIA
FI20105414A0 (en) Method and arrangement for preventing structure movement
PL2718434T3 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOUS DISEASE